Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wyeth Consumer Healthcare was a leading global provider of over-the-counter (OTC) medicines, vitamins, and nutritional supplements. The company's portfolio featured several of the world's most recognized consumer brands, including Advil, Centrum, Robitussin, ChapStick, and Preparation H. Originally operating as a division of Wyeth, it was formerly known as Whitehall-Robins Healthcare until a rebranding in 2002. In 2009, the parent company Wyeth was acquired by Pfizer in a transaction valued at approximately $68 billion. Following the merger, Wyeth Consumer Healthcare was integrated into Pfizer Consumer Healthcare. This business unit eventually became part of a joint venture with GSK and was subsequently spun off in 2022 to form the independent consumer health company Haleon.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wyeth Consumer Healthcare.